Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.34 is 54% below its 5-year average of 2.92, near the low end of its 5-year range (1.32–6.20).
As of the fiscal period ended Tuesday, June 30, 2026. 6.20% below its 12-month average of 1.43.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.34.
QUICK RATIO (ACID-TEST)
1.34
QUICK RATIO (ACID-TEST) AVG TTM
1.43
QUICK RATIO (ACID-TEST) AVG 3Y
2.41
QUICK RATIO (ACID-TEST) AVG 5Y
2.92
QUICK RATIO (ACID-TEST) AVG 10Y
3.93
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.20%
CURRENT VS 3Y AVG
-44.30%
CURRENT VS 5Y AVG
-53.97%
CURRENT VS 10Y AVG
-65.82%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-55.06%
vs the sector median at left
Axsome Therapeutics, Inc.
Market Cap
$9.11B
Quick Ratio (Acid-Test)
1.34
TTM Avg
1.43
3Y Avg
2.41
5Y Avg
2.92
Market Cap
$9.04B
Quick Ratio (Acid-Test)
N/A
TTM Avg
9.00
3Y Avg
7.15
5Y Avg
6.04
Market Cap
$9.35B
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.82
3Y Avg
1.02
5Y Avg
1.25
Market Cap
$8.78B
Quick Ratio (Acid-Test)
5.90
TTM Avg
5.80
3Y Avg
4.66
5Y Avg
4.84
Market Cap
$9.60B
Quick Ratio (Acid-Test)
0.73
TTM Avg
0.77
3Y Avg
0.86
5Y Avg
0.88
Market Cap
$8.59B
Quick Ratio (Acid-Test)
4.88
TTM Avg
4.46
3Y Avg
3.60
5Y Avg
3.01
Market Cap
$9.72B
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.82
3Y Avg
1.02
5Y Avg
1.25
Market Cap
$8.41B
Quick Ratio (Acid-Test)
1.08
TTM Avg
0.93
3Y Avg
1.08
5Y Avg
1.24
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $9.11B | 1.34 | 1.43 | 2.41 | 2.92 |
| Kymera Therapeutics, Inc. (KYMR)vs › | $9.04B | N/A | 9.00 | 7.15 | 6.04 |
| Bruker Corporation (BRKRP)vs › | $9.35B | 0.92 | 0.82 | 1.02 | 1.25 |
| Insulet Corp. (PODD)vs › | $9.39B | 1.83 | 2.42 | 2.51 | 3.28 |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | 5.90 | 5.80 | 4.66 | 4.84 |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 0.73 | 0.77 | 0.86 | 0.88 |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 4.88 | 4.46 | 3.60 | 3.01 |
| Bruker Corporation (BRKR)vs › | $9.72B | 0.92 | 0.82 | 1.02 | 1.25 |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 1.08 | 0.93 | 1.08 | 1.24 |
| Krystal Biotech, Inc. (KRYS)vs › | $9.87B | 7.96 | 8.29 | 11.86 | 13.73 |
Quick Ratio
1.34
Excludes inventory
Current Ratio
1.43
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.34 |
| 2026-03-31 | 1.32 |
| 2025-12-31 | 1.48 |
| 2025-09-30 | 1.50 |
| 2025-06-30 | 1.51 |
| 2025-03-31 | 1.96 |
| 2024-12-31 | 2.04 |
| 2024-09-30 | 2.37 |
| 2024-06-30 | 2.40 |
| 2024-03-31 | 3.09 |
| 2023-12-31 | 3.52 |
| 2023-09-30 | 4.38 |
| 2023-06-30 | 4.44 |
| 2023-03-31 | 2.95 |
| 2022-12-31 | 2.50 |
| 2022-09-30 | 4.15 |
| 2022-06-30 | 2.20 |
| 2022-03-31 | 3.54 |
| 2021-12-31 | 3.75 |
| 2021-09-30 | 4.66 |
| 2021-06-30 | 6.20 |
| 2021-03-31 | 7.61 |
| 2020-12-31 | 7.85 |
| 2020-09-30 | 9.99 |
| 2020-06-30 | 8.30 |
| 2020-03-31 | 7.57 |
| 2019-12-31 | 9.00 |
| 2019-09-30 | 2.39 |
| 2019-06-30 | 4.18 |
| 2019-03-31 | 5.68 |
| 2018-12-31 | 1.41 |
| 2018-09-30 | 1.46 |
| 2018-06-30 | 2.26 |
| 2018-03-31 | 2.95 |
| 2017-12-31 | 2.90 |
| 2017-09-30 | 3.86 |
| 2017-06-30 | 4.73 |
| 2017-03-31 | 5.53 |
| 2016-12-31 | 5.30 |
| 2016-09-30 | 5.16 |
| 2016-06-30 | 7.82 |
| 2016-03-31 | 11.51 |
| 2015-12-31 | 18.63 |
| 2015-09-30 | 2.22 |
| 2015-06-30 | 4.36 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 2.82 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
